Skip to main content

Table 1 Dosages in ANPQ3 and CQPQ14 group*

From: Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial

Days

ANPQ3 group (mg/kg body weight per day)

ANPQ3 group(mg/kg body weight per day)

Art

NQ

PQ

CQ

PQ

Day 0

5.3

2.3

0.3

12

0.3

Day 1

5.3

2.3

0.3

9

0.3

Day 2

5.3

2.3

0.3

9

0.3

Day 3–13

–

–

–

–

0.3

  1. Art artemisinin, NQ naphthoquine, PQ primaquine, CQ chloroquine
  2. *ANPQ3 denotes artemisinin-naphthoquine plus primaquine for 3 days; CQPQ14 denotes chloroquine plus primaquine for 14 days
Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us